Sowell Financial Services
BIB icon

Sowell Financial Services’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Sowell Financial Services’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-143
Closed -$12K – 771
2021
Q1 		$12K Sell
143
-96,458
-100% -$9.1M ﹤0.01% 2233
2020
Q4 		$8.34M Buy
96,601
+96,578
+419,904% +$7.47M 0.36% 63
2020
Q3 		$2K Buy
+23
New +$1.63K ﹤0.01% 2198

Other funds holding BIB

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $474M AUM 95.11% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
Capital Investment Advisors
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UMC
United Maritime Capital New York $15.2M AUM 45.42% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Sowell Financial Services's BIB Position: Q2 2021 in Review

Sowell Financial Services sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2021, closing a stake of 143 shares — an estimated $12K sold.

Sowell Financial Services first reported a position in BIB in Q3 2020 and held it in 3 quarters. The position peaked at $8.34M in Q4 2020. 36 funds tracked by Wall St. Rank hold BIB as of Q2 2021.

  • Sowell Financial Services reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 143 ProShares Ultra NASDAQ Biotechnology shares in Q2 2021, an estimated $12K.
  • Sowell Financial Services first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2020 and held it in 3 quarters.
  • Sowell Financial Services's ProShares Ultra NASDAQ Biotechnology position peaked at $8.34M in Q4 2020.
  • 36 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.